Search

everythinglearnresearchcommunity

for

Search:↓

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Hair-Thread Tourniquet Syndrome is a rare condition where hair or thread tightly wraps around a child's body part, requiring quick treatment to prevent damage.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

Teledermatology can effectively treat certain skin conditions with topical treatments, reducing the need for in-person visits.

Kinematic alignment in knee surgery often requires smaller femoral components than mechanical alignment.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Phosphatidylinositol 4-kinases are crucial for root growth, defense, and immunity in Arabidopsis thaliana.

Tofacitinib taken by mouth helps treat hair loss in children.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Erlotinib can cause persistent excessive hair growth.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

The drug combination was safe and showed promise in treating advanced tumors.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.